Autologous tumor cell surface protein

Autologous tumor cell surface proteins refer to the set of membrane proteins found on an individual patient's tumor cells that can serve as target antigens for immunotherapeutic strategies, including autologous tumor cell vaccines and personalized adoptive cell therapies. These proteins can include a broad range of molecule types (e.g., receptors, adhesion molecules, enzymes) and are characterized by their preferential or exclusive expression on tumor cells compared to normal cells. Their immunogenicity enables the patient's immune system, particularly T cells, to recognize and attack tumor cells. However, as this term does not designate a specific protein but rather a heterogeneous class, detailed properties like sequence, precise molecular function, and universal therapeutic modalities cannot be specified without additional context.

Other names

Tumor-associated antigen (autologous context)autologous tumor antigenpatient-specific tumor antigencell surface tumor antigen (autologous)

Immune-mediated tumor cell killing (via T cells, antibodies, or vaccine-induced immune responses), blockade of growth/survival signals